📊Agency Information Collection on Healthcare Research Comments Open
This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) approve an extension of the currently approved information collection "Medical Expenditures Panel Survey-- Insurance Component, (OMB No. 0935-0110)." This proposed information collection was previously published in the Federal Register on November 13, 2024 and allowed 60 days for public comment. AHRQ received comments from members of the public. The purpose of this notice is to allow an additional 30 days for public comment.
Learn More🐔FDA Updates Regulations on Food Additives for Animal Feed
The Food and Drug Administration (FDA, we, or the Agency) is amending the regulations for food additives permitted in feed and drinking water of animals to provide for the safe use of zinc L- selenomethionine as a source of selenium in complete feed for broiler chickens. This action is in response to a food additive petition filed by Zinpro Corp.
Learn More🐟South Atlantic Fishery Management Council Public Meeting Details
The South Atlantic Fishery Management Council (Council) will hold meetings of the following: Snapper Grouper Commercial Sub- Committee; Mackerel Cobia Committee; Snapper Grouper Committee; and Joint Habitat & Ecosystem and Shrimp Committee. The meeting week will also include a formal public comment session and meetings of the Full Council.
Learn More💊FDA Meeting on Reauthorization of Prescription Drug User Fee Act
The Food and Drug Administration (FDA, the Agency, or we) is hosting a public meeting to discuss proposed recommendations for the reauthorization of the Prescription Drug User Fee Act (PDUFA) for fiscal years (FYs) 2028 through 2032. PDUFA authorizes FDA to collect user fees to support the process for the review of human drug applications. The current legislative authority for PDUFA expires in September 2027. At that time, new legislation will be required for FDA to continue collecting prescription drug user fees in future fiscal years. The Federal Food, Drug, and Cosmetic Act (FD&C Act) directs that FDA begin the PDUFA reauthorization process by publishing a notice in the Federal Register requesting public input and holding a public meeting where the public may present its views on the reauthorization. FDA invites public comment as the Agency begins the process to reauthorize the program in FYs 2028 through 2032. These comments will be published and available on FDA's website.
Learn More🍯Correction of Antidumping Duty on Raw Honey from Vietnam
The U.S. Department of Commerce (Commerce) published notice in the Federal Register of April 14, 2025, in which Commerce published the affirmative antidumping duty (AD) final results in the administrative review of raw honey from the Socialist Republic of Vietnam (Vietnam) for the period of review (POR) August 25, 2021, through May 31, 2023. Commerce incorrectly identified certain companies which it found were not entitled to a separate rate. Additionally, in that notice, Commerce failed to correctly provide the complete names for certain separate rate companies.
Learn More💰Proposed Collection of ACH Vendor Payment Information by Treasury
The Department of the Treasury, as part of its continuing effort to reduce paperwork and respondent burden, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. Currently the Bureau of the Fiscal Service within the Department of the Treasury is soliciting comments concerning the ACH Vendor/Miscellaneous Payment Enrollment Form.
Learn More💻MIAX Proposes Testing Systems Access Fee for Businesses
The Miami International Securities Exchange has proposed a rule change to implement a monthly fee for accessing its testing systems environment via dedicated cross connections. This change is aimed at improving connectivity for software testing and certification, critical for upcoming Exchange technology changes. The fee structure applies uniformly to all market participants using either dedicated connections or free VPN access, ensuring equal opportunity without competitive advantage.
Learn More🐋Notice of Application for Marine Mammal Research Permit
Notice is hereby given that Allyson Hindle, Ph.D., University of Nevada Las Vegas, 4505 South Maryland Parkway, MS 4004, Las Vegas, NV 89154, has applied in due form for a permit to receive, import, and export parts from marine mammals for scientific research.
Learn More⚛️Constellation Energy Withdraws License Amendment for Quad Cities Nuclear Station
The U.S. Nuclear Regulatory Commission (NRC) is announcing the withdrawal of a license amendment application from Constellation Energy Generation, LLC (the licensee), dated November 4, 2024, for a proposed amendment to Quad Cities Nuclear Power Station, Units 1 and 2, License Nos. DPR-29 and DPR-30. The proposed amendment would have extended the Completion Time for Technical Specifications 3.6.4.3, "Standby Gas Treatment (SGT) System," Required Action D.1 on a one-time basis to support repair of the SGT common discharge exhaust line.
Learn More📄DOE Notice on Technology Partnerships Ombudsmen Reporting Requirements
The Department of Energy (DOE) has submitted an information collection request to the OMB for extension under the provisions of the Paperwork Reduction Act of 1995. The information collection requests a three-year extension of its collection, titled Technology Partnerships Ombudsmen Reporting Requirements, OMB Control Number 1910-5118. The proposed collection will identify the number and nature of complaints received and resolved by technology partnership ombuds related to technology partnerships, patents, and licenses.
Learn More